1.	Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants Phase: Phase IV Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: A1501038, NCT00143312
2.	Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 2008-0443, NCT00904995
3.	Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 9766-CL-0104, WSA-CS-004, 2006-003868-59, NCT00412893
4.	Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection Phase: Phase II Type: Biomarker/Laboratory analysis, Supportive care Status: Closed Age: 2 to 15 Sponsor: Pharmaceutical / Industry Protocol IDs: A1501096, NCT01383993
5.	An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: Not specified Sponsor: Other Protocol IDs: PMH-VOR, NCT01321372